Atlas Trials

An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)

Clinical trial NCT01012622 · COMPLETED

Trial details

NCT number
NCT01012622
Sponsor
Janssen Korea, Ltd., Korea
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Attention Deficit Disorder With Hyperactivity
Start date
2008-09-01
Primary completion
2009-08-01
Enrollment
142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.